Skip to main content

Jiangsu Hengrui Pharmaceuticals

Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a research-based biopharmaceutical enterprise in China involved in the discovery, manufacturing, and marketing of innovative and generic medicines. The company focuses on oncology, anesthesia, contrast agents, cardiovascular, and metabolic disease treatments, developing small-molecule formulations and biologics. Principal revenue drivers stem from commercial domestic sales of innovative proprietary prescription oncology therapies, generic formulations, and active pharmaceutical ingredients. Jiangsu Hengrui serves public and private hospital systems, medical research clinics, and healthcare distribution networks across mainland China and overseas markets. The enterprise occupies a leading market position as one of China's largest pharmaceutical companies by market value and research and development expenditure. Jiangsu Hengrui Pharmaceuticals Co., Ltd. is headquartered in Lianyungang, China, and its common shares are listed on the Shanghai Stock Exchange.

15 of the funds FundTelligence covers report a position in Jiangsu Hengrui Pharmaceuticals.

Legal name
Jiangsu Hengrui Pharmaceuticals Co. Ltd.
Sector
Health Care
Country
China
Funds holding it
15
Exposure themes
Multiple, Treatment, Women's Health

Funds holding Jiangsu Hengrui Pharmaceuticals

Showing the 8 largest of 15 funds holding it.

Loading...